Zobrazeno 1 - 10
of 219
pro vyhledávání: '"Shigeo, Fuji"'
Autor:
Shigeo Fuji, Reiko Sakai
Publikováno v:
eJHaem, Vol 5, Iss 1, Pp 274-275 (2024)
Externí odkaz:
https://doaj.org/article/c4b6748419f34ee8a931cebb65981d9e
Autor:
Nobuaki Nakano, Hideki Nakasone, Shigeo Fuji, Akihito Shinohara, Ritsuro Suzuki, Atae Utsunomiya, Tetsuya Eto, Satoko Morishima, Kazuhiro Ikegame, Yasutaka Kakinoki, Ken-ichi Matsuoka, Yasuo Mori, Youko Suehiro, Naoyuki Uchida, Ayumu Ito, Noriko Doki, Yukiyasu Ozawa, Junya Kanda, Yoshinobu Kanda, Takahiro Fukuda, Yoshiko Atsuta, Masao Ogata
Publikováno v:
The Lancet Regional Health. Western Pacific, Vol 40, Iss , Pp 100902- (2023)
Summary: Background: Human T-cell leukemia virus type I (HTLV-1) is a retrovirus known to cause adult T-cell leukemia/lymphoma (ATL). There are few reports on hematopoietic stem cell transplantation (HSCT) for d HTLV-1 carriers with diseases other th
Externí odkaz:
https://doaj.org/article/a79f543a74c44bd68df2297e75f9834a
Autor:
Shigeo Fuji, Akitoshi Hakoda, Junya Kanda, Takahiro Fukuda, Noriko Doki, Yuta Katayama, Naoyuki Uchida, Yukiyasu Ozawa, Yoshinobu Kanda, Masatsugu Tanaka, Keisuke Kataoka, Takahide Ara, Masashi Sawa, Makoto Onizuka, Yasushi Onishi, Takafumi Kimura, Tatsuo Ichinohe, Yoshiko Atsuta, Ayumi Shintani, Satoko Morishima
Publikováno v:
HemaSphere, Vol 7, p e0799573 (2023)
Externí odkaz:
https://doaj.org/article/ca7d6ed0ed1d4941ac0d6d84354031ca
Publikováno v:
Clinical Hematology International, Vol 4, Iss 3, Pp 89-98 (2022)
Abstract Hematopoietic stem cell transplantation (HSCT) is an integral part of the treatment strategy in patients with a hematological disorder. Chemotherapy-induced nausea and vomiting (CINV) is still an issue in patients who undergo HSCT. While sev
Externí odkaz:
https://doaj.org/article/d572872d626945c5b4cfd7ae41e7a6fa
Autor:
Shigeo Fuji, Jun-ichirou Yasunaga, Eri Watanabe, Masao Matsuoka, Kaoru Uchimaru, Jun Ishikawa
Publikováno v:
Haematologica, Vol 107, Iss 11 (2022)
Externí odkaz:
https://doaj.org/article/fa73d21ee11e4d779ca429664286b2cb
Publikováno v:
The Journal of the International Society of Physical and Rehabilitation Medicine, Vol 2, Iss 1, Pp 54-61 (2019)
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is increasingly used in the treatment of hematologic cancers such as leukemias, lymphomas, and myeloma and for other hematologic disorders such as primary immunodeficiency, aplastic anemi
Externí odkaz:
https://doaj.org/article/4ee146bd01664ab78f39af3c2d943527
Autor:
Akihiro Ohmoto, Shigeo Fuji
Publikováno v:
Expert Review of Hematology. :1-7
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2481c0b2a978f86d6e0a8755f0f2aa41
https://doi.org/10.1080/17474086.2023.2215424
https://doi.org/10.1080/17474086.2023.2215424
Autor:
Keiji, Okinaka, Yukihiro, Akeda, Yoshihiro, Inamoto, Shigeo, Fuji, Ayumu, Ito, Takashi, Tanaka, Saiko, Kurosawa, Sung-Won, Kim, Ryuji, Tanosaki, Takuya, Yamashita, Chikako, Ohwada, Keiji, Kurata, Takeshi, Mori, Masahiro, Onozawa, Kuniko, Takano, Hiroki, Yokoyama, Katsuyoshi, Koh, Koji, Nagafuji, Kazutaka, Nakayama, Toru, Sakura, Tsutomu, Takahashi, Kazunori, Oishi, Takahiro, Fukuda
Publikováno v:
Clinical Microbiology and Infection. 29:482-489
This multicentre, phase 2, randomized, controlled study of allogeneic haematopoietic stem cell transplantation (allo-HSCT) recipients compared the immunogenicity of two anti-pneumococcal vaccine regimens: four doses of 13-valent pneumococcal conjugat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69ef96293664a26ddf0b4c97d93174cd
https://doi.org/10.1016/j.cmi.2022.12.007
https://doi.org/10.1016/j.cmi.2022.12.007
Autor:
Hitoshi Yoshida, Midori Koike, Yuma Tada, Keiichi Nakata, Akihisa Hino, Shigeo Fuji, Hiroaki Masaie, Chihiro Oka, Akemi Higeno, Atushi Idota, Tomoyuki Yamasaki, Jun Ishikawa
Publikováno v:
International Journal of Hematology-Oncology and Stem Cell Research, Vol 14, Iss 1 (2020)
Background: Advances of allogeneic hematopoietic cell transplantation (allo-HCT) have brought long-term survival to the patients with hematologic malignancies. Chronic graft-versus-host disease (GVHD) is one of major problems for the long-survivors a
Externí odkaz:
https://doaj.org/article/95aacee902ef4e93941f1fa45c0e918d
Autor:
Masahito Tokunaga, Nobuaki Nakano, Shigeo Fuji, Atsushi Wake, Atae Utsunomiya, Ayumu Ito, Tetsuya Eto, Toshiro Kawakita, Yasuo Mori, Yukiyoshi Moriuchi, Youko Suehiro, Yasuhiko Miyazaki, Naoyuki Uchida, Yasushi Sawayama, Kenji Ishitsuka, Junya Kanda, Takafumi Kimura, Tatsuo Ichinohe, Yoshiko Atsuta, Takahiro Fukuda, Makoto Yoshimitsu, Koji Kato
Publikováno v:
Bone Marrow Transplantation. 58:462-464
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5cbe20b73c2de189204d70c1cd5912eb
https://doi.org/10.1038/s41409-023-01919-3
https://doi.org/10.1038/s41409-023-01919-3